Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New 3D mapping technology reveals how hair follicles form over time

21

Aug 2026

New 3D mapping technology reveals how hair follicles form over time

​In a new research report, scientists at Johns Hopkins Medicine say they have developed a technology that allows them to capture a 3D molecular "snapshot" of hundreds of hair follicles as they develop and then reconstruct the fourth dimension - time - to effectively create a stop-motion animation of how this organ forms.

Study highlights strengths and barriers of remote heart failure care

21

Aug 2026

Study highlights strengths and barriers of remote heart failure care

Interviews with patients hospitalized for heart failure, caregivers, providers, and organizational leaders highlighted several strengths of Mighty Heart (a major clinical trial examining the effectiveness of in home and telehealth-enabled visits from paramedics) that may support its adoption and implementation across health systems, a Columbia Nursing-led study finds.

Review outlines how SIRT3 protein regulates global metabolic disorders

21

Aug 2026

Review outlines how SIRT3 protein regulates global metabolic disorders

A comprehensive review published in Engineering systematically outlines the regulatory capacity of silent information regulator 3 (SIRT3), a mitochondrial deacetylase termed the "head goose molecule", and its negentropic mechanism for intervening global metabolic disorders including type 2 diabetes, obesity, and steatotic liver disease.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.